Phibro Animal Health Corporation
PAHC
$17.03
$0.4953.00%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 12.63% | 7.17% | 4.07% | 2.19% | 1.02% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 12.63% | 7.17% | 4.07% | 2.19% | 1.02% |
| Cost of Revenue | 10.09% | 5.59% | 3.59% | 2.74% | 1.11% |
| Gross Profit | 18.44% | 10.78% | 5.16% | 0.96% | 0.83% |
| SG&A Expenses | 1.37% | 3.05% | 13.45% | -1.98% | -1.09% |
| Depreciation & Amortization | -1.94% | -1.94% | -1.94% | 2.15% | 2.15% |
| Other Operating Expenses | 1,192.92% | -39.05% | -39.05% | -100.00% | -95.05% |
| Total Operating Expenses | 8.71% | 5.04% | 5.77% | 3.50% | 2.59% |
| Operating Income | 75.62% | 41.36% | -17.41% | -14.72% | -18.87% |
| Income Before Tax | 20.11% | -11.34% | -79.81% | -42.33% | -50.41% |
| Income Tax Expenses | 8.54% | -5.21% | -60.40% | -22.05% | -34.92% |
| Earnings from Continuing Operations | 30.53% | -16.05% | -92.59% | -53.97% | -59.17% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 30.53% | -16.05% | -92.59% | -53.97% | -59.17% |
| EBIT | 75.62% | 41.36% | -17.41% | -14.72% | -18.87% |
| EBITDA | 52.43% | 28.37% | -9.88% | -8.76% | -12.30% |
| EPS Basic | 30.51% | -16.04% | -92.58% | -53.97% | -59.16% |
| Normalized Basic EPS | 87.65% | 14.43% | -68.65% | -38.70% | -49.31% |
| EPS Diluted | 31.21% | -16.42% | -93.03% | -54.21% | -59.38% |
| Normalized Diluted EPS | 87.15% | 14.26% | -68.72% | -38.72% | -49.31% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.25% | 0.12% | 0.07% | 0.01% | 0.00% |
| Dividend Per Share | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Payout Ratio | -0.23% | 0.19% | 12.50% | 1.17% | 1.45% |